Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (1059)	7/14/1999 12:36:00 PM
From: N	Respond to of 1972

Probable cause? Amgen's earnings were good...out yesterday. Message 10498534 "...Amgen (Nasdaq: AMGN) announced earnings early to quell the good rumors. Results clobbered expectations. Revenue grew 25% to $738 million and earnings per share rose 21% to $0.50, topping the $0.46 estimate by 8.6%. The $72 stock is at 37 times the new estimates of $1.95 per share in '99 earnings..." And chart looks good, for the voodoo, eye of newt inclined clearstation.com Nancy